The end of ICP Bio ?

The struggling local biotech that manufactures and markets products for use in biopharmaceutical manufacturing, diagnostics and animal reproduction, has been placed under receivership while under voluntary administration. Despite the recent improvements in the companies performance and position due to restructuring and focusing, sales expectations have failed to eventuate. It is an unfortunate conclusion to the company’s downfall but one that is not uncommon to the global biotech industry.

Herald LINK


One response to “The end of ICP Bio ?

  1. ICP Bio has always had trouble meeting its debt. We were a supplier to them and chose to stop dealing with them about 1.5 years ago, as we considered them too high a risk to deal with. The signs of being in debt were all there, It has always been a matter of when they fall over not if, I am surprised that it took this long.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s